Literature DB >> 27633306

Effect of co-transfection of miR-520c-3p and miR-132 on proliferation and apoptosis of hepatocellular carcinoma Huh7.

Chang-Jiang Lei1, Chun Yao2, De-Ke Li3, Zhi-Xiong Long4, Yuan Li1, Dan Tao5, Yan-Ping Liou5, Jiang-Zhou Zhang5, Ning Liu1.   

Abstract

OBJECTIVE: To investigate the effects of co-transfection of miR-520c-3p and miR-132 on proliferation and apoptosis of hepatocellular carcinoma Huh7.
METHODS: Hepatocellular carcinoma Huh7 was cultured in vitro and lipidosome was used to transfect miR-520c-3p and miR-132, respectively or together. The effects of transfection of miR-520c-3p and miR-132 on proliferation and apoptosis of Huh7 were detected by CCK8 and Annexin V staining and flow cytometry, and the expression level of the targeted gene of over-expressed miR-520c-3p and miR-132 was determined by Western blot and realtime PCR.
RESULTS: Compared with the control group, the proliferation ability of Huh7 of the single transfected and co-transfected miR-520c-3p and miR-132 decreased significantly, and the apoptosis ratio increased distinctly (P < 0.05). Besides, the effect of the co-transfection group was better than that of the single transfection group. The protein levels of GPC3 (Glypican-3) and YAP (Yes-associated protein), the target genes transfected only by miR-520c-3p and miR-132, respectively, reduced obviously (P < 0.05), which was similar with the co-infected cells, but cells transfected by miR-132 only showed a decrease of YAP.
CONCLUSIONS: The co-transfection of miR-520c-3p and miR-132 can target-regulate the expression of GPC3 and YAP, enhance the exhibition effect on proliferation of hepatocellular carcinoma Huh7 and induce cell apoptosis synergistically.
Copyright © 2016 Hainan Medical College. Production and hosting by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Apoptosis; Liver cancer; MiR-132; Proliferation; miR-520c-3p

Year:  2016        PMID: 27633306     DOI: 10.1016/j.apjtm.2016.07.015

Source DB:  PubMed          Journal:  Asian Pac J Trop Med        ISSN: 1995-7645            Impact factor:   1.226


  6 in total

1.  MicroRNA-132 suppresses cell proliferation in human breast cancer by directly targeting FOXA1.

Authors:  Dan Wang; Jin Ren; Hui Ren; Jin-Ling Fu; Dan Yu
Journal:  Acta Pharmacol Sin       Date:  2017-08-17       Impact factor: 6.150

2.  Unveiling massive numbers of cancer-related urinary-microRNA candidates via nanowires.

Authors:  Takao Yasui; Takeshi Yanagida; Satoru Ito; Yuki Konakade; Daiki Takeshita; Tsuyoshi Naganawa; Kazuki Nagashima; Taisuke Shimada; Noritada Kaji; Yuta Nakamura; Ivan Adiyasa Thiodorus; Yong He; Sakon Rahong; Masaki Kanai; Hiroshi Yukawa; Takahiro Ochiya; Tomoji Kawai; Yoshinobu Baba
Journal:  Sci Adv       Date:  2017-12-15       Impact factor: 14.136

3.  Identification of differential plasma miRNA profiles in Chinese workers with occupational lead exposure.

Authors:  Ming Xu; Zhengmin Yu; Feifei Hu; Hongbing Zhang; Lixin Zhong; Lei Han; Yan An; Baoli Zhu; Hengdong Zhang
Journal:  Biosci Rep       Date:  2017-10-31       Impact factor: 3.840

4.  Epigenetic silencing of miR-520c leads to induced S100A4 expression and its mediated colorectal cancer progression.

Authors:  Giridhar Mudduluru; Katharina Ilm; Steffen Fuchs; Ulrike Stein
Journal:  Oncotarget       Date:  2017-03-28

Review 5.  MicroRNAs Regulating Hippo-YAP Signaling in Liver Cancer.

Authors:  Na-Hyun Lee; So Jung Kim; Jeongeun Hyun
Journal:  Biomedicines       Date:  2021-03-30

6.  Overexpression of microRNA-132 enhances the radiosensitivity of cervical cancer cells by down-regulating Bmi-1.

Authors:  Gui-Feng Liu; Shu-Hua Zhang; Xue-Feng Li; Li-Yan Cao; Zhan-Zhao Fu; Shao-Nan Yu
Journal:  Oncotarget       Date:  2017-08-18
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.